TrialThe Journal of infectious diseases2025

Pharmacokinetics and Safety of Clofazimine in Children With Rifampicin-Resistant Tuberculosis.

Jennifer A Hughes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.